성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Respiratory Distress Syndrome | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Respiratory Distress Syndrome

NCLEX Review Guide: Respiratory Distress Syndrome in Newborns

Pathophysiology

Definition and Etiology

  • Respiratory Distress Syndrome (RDS) is a breathing disorder primarily affecting premature infants caused by surfactant deficiency in immature lungs. Surfactant is a lipoprotein that reduces surface tension in the alveoli, preventing collapse during expiration.
  • The primary risk factor is prematurity, with incidence inversely related to gestational age - affecting approximately 60% of infants born at less than 28 weeks gestation, but only 30% of those born at 28-34 weeks.

Key Points

  • RDS occurs primarily in premature infants due to insufficient surfactant production
  • Risk increases with decreasing gestational age and birth weight
  • Additional risk factors include maternal diabetes, cesarean delivery without labor, and perinatal asphyxia

Pathological Changes

  • Without adequate surfactant, alveoli collapse during expiration (atelectasis), leading to decreased lung compliance, increased work of breathing, and ventilation-perfusion mismatch.
  • Progressive hypoxemia and respiratory acidosis develop as the infant struggles to maintain adequate gas exchange, potentially leading to pulmonary vasoconstriction and persistent pulmonary hypertension.

Key Points

  • Surfactant deficiency → alveolar collapse → decreased lung compliance → increased work of breathing
  • Ventilation-perfusion mismatch leads to hypoxemia and respiratory acidosis

Clinical Manifestations

Signs and Symptoms

  • Symptoms typically appear within minutes to hours after birth, with progressive respiratory distress that includes tachypnea (rate >60/min), nasal flaring, grunting, and intercostal/subcostal retractions.
  • Cyanosis may be present even with supplemental oxygen, and breath sounds may be diminished with fine crackles on auscultation.

Clinical Scenario

A 32-week gestational age male infant is born via emergency cesarean section. Within 30 minutes of birth, the nurse observes respiratory rate of 75 breaths/minute, audible grunting, nasal flaring, and intercostal retractions. Oxygen saturation is 88% despite supplemental oxygen at 40%. These signs strongly suggest RDS and require immediate medical intervention.

Key Points

  • Classic signs include tachypnea, nasal flaring, grunting, and retractions (the "RDS triad")
  • Symptoms typically appear within minutes to hours after birth
  • Severity progressively worsens over the first 48-72 hours if untreated

Diagnosis

Diagnostic Criteria

  • Diagnosis is based on clinical presentation, chest radiography, and blood gas analysis. Chest X-rays typically show a diffuse "ground glass" appearance with air bronchograms.
  • Arterial blood gases reveal hypoxemia (decreased PaO₂), hypercapnia (increased PaCO₂), and respiratory acidosis (decreased pH), with severity depending on disease progression.

Key Points

  • Classic X-ray findings: diffuse "ground glass" appearance with air bronchograms
  • ABG findings: hypoxemia, hypercapnia, and respiratory acidosis
  • Differential diagnosis includes transient tachypnea of newborn, pneumonia, and meconium aspiration syndrome

Differential Diagnosis of Respiratory Distress in Newborns

Condition Onset Clinical Features X-ray Findings
Respiratory Distress Syndrome Minutes to hours after birth Progressive respiratory distress, grunting, retractions, cyanosis Diffuse "ground glass" appearance, air bronchograms
Transient Tachypnea of Newborn Immediately after birth Mild to moderate tachypnea, minimal retractions, improves within 24-72 hours Hyperinflation, fluid in fissures, perihilar streaking
Meconium Aspiration Syndrome At birth Respiratory distress, barrel chest, meconium-stained amniotic fluid Patchy infiltrates, hyperinflation, flattened diaphragm
Neonatal Pneumonia Variable Respiratory distress, temperature instability, lethargy Patchy infiltrates, often unilateral or asymmetric

Management

Preventive Measures

  • Antenatal corticosteroids administered to mothers at risk for preterm delivery between 24-34 weeks gestation accelerate fetal lung maturity and reduce the incidence and severity of RDS by stimulating surfactant production.
  • Delaying delivery when possible until fetal lung maturity is achieved, as confirmed by testing amniotic fluid for lecithin/sphingomyelin (L/S) ratio >2:1 or presence of phosphatidylglycerol.

Key Points

  • Antenatal corticosteroids (betamethasone or dexamethasone) reduce RDS incidence by 40-60%
  • Most effective when administered 24 hours to 7 days before delivery
  • L/S ratio >2:1 indicates lung maturity

Surfactant Replacement Therapy

  • Exogenous surfactant administration is the cornerstone of RDS treatment, typically given via endotracheal tube as prophylaxis in extremely premature infants or as rescue therapy when RDS is diagnosed.
  • Multiple preparations are available, including natural (animal-derived) and synthetic surfactants, with administration usually performed within the first hours of life.

Important Alert: Monitor infants closely during and after surfactant administration for acute complications including oxygen desaturation, bradycardia, endotracheal tube obstruction, and pulmonary hemorrhage. Have resuscitation equipment readily available.

Key Points

  • Surfactant therapy significantly reduces mortality and air leak complications
  • May require multiple doses for optimal effect (typically 6-12 hours apart)
  • Rapid improvement in oxygenation often occurs after administration

Respiratory Support

  • Respiratory support ranges from supplemental oxygen to mechanical ventilation based on disease severity. Continuous Positive Airway Pressure (CPAP) is often the initial intervention for mild to moderate RDS.
  • For severe cases, mechanical ventilation with positive end-expiratory pressure (PEEP) may be necessary to maintain alveolar recruitment, though strategies aim to minimize ventilator-induced lung injury.

    CPAP Administration Procedure

  1. Ensure equipment is properly assembled and functioning
  2. Set initial CPAP pressure between 5-8 cm H₂O
  3. Select appropriate interface (nasal prongs, mask, or nasopharyngeal tube)
  4. Position the infant supine with slight neck extension
  5. Apply interface gently and secure without excessive pressure
  6. Monitor vital signs, work of breathing, and oxygen saturation continuously
  7. Adjust FiO₂ to maintain target oxygen saturation (typically 90-95%)

Key Points

  • CPAP helps maintain functional residual capacity and prevents alveolar collapse
  • Target oxygen saturation is typically 90-95% to avoid both hypoxemia and hyperoxemia
  • Ventilation strategies focus on lung protection to prevent bronchopulmonary dysplasia

Supportive Care

  • Maintain neutral thermal environment and adequate hydration while carefully monitoring fluid status, as infants with RDS are at risk for both dehydration and fluid overload.
  • Provide adequate nutrition through parenteral nutrition initially, with gradual introduction of enteral feeding as respiratory status stabilizes and the risk of necrotizing enterocolitis is minimized.

Key Points

  • Monitor for complications including patent ductus arteriosus, intraventricular hemorrhage, and infection
  • Careful fluid management is essential to prevent pulmonary edema
  • Minimize handling and provide developmentally supportive care

Complications and Prognosis

Short-term Complications

  • Air leak syndromes such as pneumothorax and pulmonary interstitial emphysema can occur, particularly with mechanical ventilation. Patent ductus arteriosus (PDA) is common due to the effects of hypoxemia and acidosis on the ductal tissue.
  • Intraventricular hemorrhage risk is increased, particularly in extremely premature infants, due to fragile germinal matrix vasculature and fluctuations in cerebral blood flow.

Key Points

  • Air leak syndromes require prompt recognition and intervention
  • PDA may require medical treatment with indomethacin or ibuprofen, or surgical ligation
  • Regular cranial ultrasounds monitor for intraventricular hemorrhage

Long-term Complications

  • Bronchopulmonary dysplasia (BPD) is the most significant long-term pulmonary complication, characterized by chronic lung disease with oxygen dependency beyond 28 days of life or 36 weeks corrected gestational age.
  • Neurodevelopmental impairment risk is increased, particularly in infants with severe RDS or those who develop complications such as intraventricular hemorrhage or periventricular leukomalacia.

Key Points

  • BPD risk factors include extreme prematurity, oxygen toxicity, volutrauma, and infection
  • Long-term follow-up is essential for monitoring growth, pulmonary function, and development
  • Some infants may require home oxygen therapy and specialized follow-up care

Prognosis

  • Outcomes have significantly improved with advances in neonatal intensive care, surfactant therapy, and ventilation strategies. Survival rates exceed 95% for infants >28 weeks gestation with RDS.
  • Prognosis is primarily determined by gestational age, birth weight, severity of RDS, presence of complications, and response to treatment.

Key Points

  • Most infants with mild to moderate RDS recover without long-term sequelae
  • Extremely premature infants (<28 weeks) have higher risks of complications and long-term morbidity
  • Early intervention services benefit infants at risk for developmental delays

Nursing Care

Assessment

  • Perform thorough respiratory assessment every 1-2 hours, including respiratory rate, work of breathing, breath sounds, oxygen saturation, and blood gas values.
  • Monitor vital signs continuously, particularly heart rate, respiratory rate, blood pressure, and temperature, noting any deviations that may indicate deterioration or improvement.

Key Points

  • Assess for Silverman-Anderson score components: chest movement, intercostal retractions, xiphoid retractions, nares dilation, and expiratory grunting
  • Monitor for signs of deterioration requiring escalation of support
  • Assess pain and comfort level regularly using appropriate neonatal pain scales

Nursing Interventions

  • Position infant to optimize respiratory function, typically in supine or side-lying position with neck slightly extended to maintain airway patency. Use containment and positioning aids for developmental support.
  • Provide meticulous care of respiratory equipment including proper sizing and positioning of CPAP interfaces, securing endotracheal tubes at correct depth, and monitoring for pressure injuries from devices.

Respiratory Distress Signs in Newborns - "RETRACTIONS"

R - Rate increased (tachypnea >60/min)
E - Expiratory grunting
T - Tachycardia
R - Retractions (intercostal, subcostal, suprasternal)
A - Air hunger (gasping, mouth breathing)
C - Cyanosis (central)
T - Twitching nostrils (nasal flaring)
I - Irregular breathing
O - Oxygen need increases
N - Nasal flaring
S - See-saw respirations

Important Alert: Sudden changes in oxygen requirement, increased work of breathing, or decreased breath sounds may indicate pneumothorax, endotracheal tube displacement, or mucus plugging requiring immediate intervention. Have emergency equipment readily available at bedside.

Key Points

  • Cluster care activities to minimize handling and stress
  • Maintain skin integrity with frequent position changes and pressure point assessment
  • Provide developmentally supportive care including minimal stimulation, noise reduction, and cycled lighting

Family Support and Education

  • Provide clear, consistent information to parents about RDS, treatment plan, and expected course. Encourage parental involvement in care when appropriate.
  • Support bonding through skin-to-skin contact when stable, facilitated tucking, and comfort measures that parents can provide even when direct care is limited.

Key Points

  • Explain equipment, alarms, and monitoring in simple, understandable terms
  • Prepare parents for the appearance of their infant with respiratory support
  • Connect families with support resources and parent-to-parent programs

Summary of Key Points

  • Respiratory Distress Syndrome is primarily a disease of premature infants caused by surfactant deficiency, leading to alveolar collapse and increased work of breathing.
  • Classic clinical manifestations include tachypnea, nasal flaring, grunting, retractions, and cyanosis appearing within hours of birth.
  • Management includes surfactant replacement therapy, respiratory support ranging from CPAP to mechanical ventilation, and comprehensive supportive care.
  • Prevention strategies focus on antenatal corticosteroids for mothers at risk of preterm delivery between 24-34 weeks gestation.
  • Nursing care emphasizes respiratory assessment, positioning, equipment management, and family support.

Commonly Confused Points

Concept Common Misconception Correct Understanding
RDS vs. TTN All respiratory distress in newborns is RDS RDS is specifically due to surfactant deficiency, while TTN results from delayed clearance of fetal lung fluid
Grunting Grunting indicates pain or discomfort Grunting is a compensatory mechanism to maintain end-expiratory pressure and prevent alveolar collapse
Oxygen Therapy Higher oxygen levels are always better Oxygen is a medication with potential toxicity; target saturation ranges (90-95%) balance hypoxemia risks with hyperoxemia risks
Surfactant Therapy One dose of surfactant is curative Multiple doses may be needed, and surfactant is supportive while the infant develops endogenous production

Study Tips

RDS Risk Factors - "SURFACTANT"

S - Small gestational age (prematurity)
U - Underdeveloped lungs
R - Respiratory system immaturity
F - Family history of RDS
A - Asphyxia (perinatal)
C - Cesarean delivery without labor
T - Twins/multiple births
A - Acidosis
N - Neonatal stress (cold, hypoglycemia)
T - Type 1 diabetes in mother

Remember Chest X-ray Findings in RDS - "GLASS"

G - Ground glass appearance
L - Low lung volumes
A - Air bronchograms visible
S - Small, underinflated lungs
S - Symmetric bilateral involvement

NCLEX Tips

  • Focus on assessment findings that require immediate intervention
  • Understand priorities in care - respiratory stabilization always comes first
  • Know normal values for neonatal vital signs and ABGs to identify deviations
  • Remember developmental care principles alongside medical interventions

Quick Check: Test Your Knowledge

  1. What is the primary cause of Respiratory Distress Syndrome in newborns?
  2. List three classic clinical manifestations of RDS.
  3. What is the significance of "ground glass appearance" on chest X-ray?
  4. Why is antenatal corticosteroid administration important for mothers at risk of preterm delivery?
  5. What are appropriate target oxygen saturation levels for an infant with RDS?

Common Pitfalls

  • Confusing RDS with other causes of neonatal respiratory distress (TTN, MAS, pneumonia)
  • Failing to recognize the importance of positioning in optimizing respiratory function
  • Overlooking the risk of oxygen toxicity when managing hypoxemia
  • Not considering fluid status when managing respiratory symptoms
  • Focusing solely on respiratory management while neglecting developmental care

Self-Assessment Checklist

  • I can explain the pathophysiology of RDS
  • I can identify the classic clinical manifestations of RDS
  • I understand the diagnostic criteria and relevant testing
  • I can describe appropriate management strategies including surfactant therapy
  • I know the nursing priorities in caring for an infant with RDS
  • I can explain potential complications and preventive measures
  • I understand the importance of family support and education

Remember, understanding RDS is crucial for providing excellent care to vulnerable newborns. Your knowledge and attentiveness can make a significant difference in these infants' outcomes. Stay focused on assessment skills, early recognition of changes, and evidence-based interventions. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.